We are live on ! Find out more
OSCR icon

Oscar Health

188 hedge funds and large institutions have $1.4B invested in Oscar Health in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 63 increasing their positions, 55 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more call options, than puts

Call options by funds: $12.4M | Put options by funds: $4.65M

70% more capital invested

Capital invested by funds: $820M → $1.4B (+$576M)

38% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 32

15% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 55

6% more funds holding

Funds holding: 177188 (+11)

1.17% more ownership

Funds ownership: 78.75%79.92% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

Holders
188
Holders Change
+11
Holders Change %
+6.21%
% of All Funds
2.74%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
44
Increased
63
Reduced
55
Closed
32
Calls
$12.4M
Puts
$4.65M
Net Calls
+$7.72M
Net Calls Change
+$5.21M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$131M +$7.75M +1,122,833 +8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$130M +$807K +116,978 +0.8%
DIG
3
Dragoneer Investment Group
California
$116M +$31.6M +4,576,137 +56%
DM
4
Deerfield Management
New York
$103M +$77.6M +11,246,820 New
VS
5
VK Services
California
$62.7M -$33.5M -4,856,214 -41%
SAM
6
Southeastern Asset Management
Tennessee
$52.3M -$11.7M -1,689,008 -23%
F
7
Formation8
California
$47.5M +$35.8M +5,189,028 New
TCMNY
8
Thrive Capital Management (New York)
New York
$43.5M
Millennium Management
9
Millennium Management
New York
$35.4M -$314K -45,564 -1%
AA
10
Ancient Art
Texas
$34.1M +$6.46M +936,763 +34%
Morgan Stanley
11
Morgan Stanley
New York
$32.2M +$18M +2,610,989 +287%
State Street
12
State Street
Massachusetts
$31.8M +$602K +87,279 +3%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$29.4M +$1.39M +201,706 +7%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$28.9M +$2.71M +392,837 +14%
Citadel Advisors
15
Citadel Advisors
Florida
$26.4M +$1.85M +267,523 +10%
Renaissance Technologies
16
Renaissance Technologies
New York
$26M -$1.53M -221,500 -7%
GGHC
17
Gilder Gagnon Howe & Co
New York
$25.9M +$3.39M +491,861 +21%
Capital World Investors
18
Capital World Investors
California
$25.2M
N
19
Nuveen
North Carolina
$21.1M +$415K +60,102 +3%
GCGM
20
General Catalyst Group Management
Massachusetts
$19.3M -$31.6M -4,576,137 -68%
ITP
21
Iron Triangle Partners
Connecticut
$18.8M +$14.2M +2,052,551 New
Point72 Asset Management
22
Point72 Asset Management
Connecticut
$18.3M +$2.73M +396,200 +25%
GCM
23
Glynn Capital Management
California
$17.5M
Two Sigma Advisers
24
Two Sigma Advisers
New York
$16.8M -$199K -28,900 -2%
Two Sigma Investments
25
Two Sigma Investments
New York
$16.2M -$832K -120,582 -6%

OSCR Hedge Fund Activity: Q4 2023 in Review

188 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Oscar Health (OSCR) for Q4 2023, worth a combined $1.4B — up 70% from $820M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new OSCR positions and 32 closed out — a net gain of 12 holders — while 63 added to existing stakes and 55 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $77.6M. The largest seller was Alphabet Inc, cutting an estimated $88.7M.

  • 188 institutional investors held Oscar Health (OSCR) as of Q4 2023, up from 177 in Q3 2023.
  • Funds reported $1.4B of Oscar Health stock for Q4 2023, up 70% quarter-over-quarter.
  • 44 funds opened new Oscar Health positions in Q4 2023 and 32 closed out, a net change of +12 holders.
  • The largest Oscar Health buyer in Q4 2023 was Deerfield Management, an estimated $77.6M added.
  • The largest Oscar Health seller in Q4 2023 was Alphabet Inc, an estimated $88.7M sold.

Based on aggregated 13F filings for Q4 2023.